667 results match your criteria: "the Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital[Affiliation]"

The integrated molecular and histological analysis defines subtypes of esophageal squamous cell carcinoma.

Nat Commun

October 2024

National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450052, People's Republic of China.

Article Synopsis
  • Esophageal squamous cell carcinoma (ESCC) shows high variability and its complex molecular and immune landscape complicates personalized treatment development.
  • Through genomic and AI-driven analysis of 120 Chinese ESCC cases, researchers identified four subtypes—differentiated, metabolic, immunogenic, and stemness—each with distinct features.
  • The stemness subtype has the worst prognosis and shows immune evasion traits, with high levels of intratumoural diversity, while specific markers like XCL1 influence both immune response and chemotherapy effectiveness.
View Article and Find Full Text PDF

Variant acute promyelocytic leukemia (APL) and APL-like leukemia are rare types of APL, with t (16;17) chromosome abnormality being even rarer. An APL-like patient with t (16;17) chromosome abnormality, which was characterized by bone, lymph node, and central nervous system involvement, was admitted to our hospital. He achieved complete remission after several cycles of chemotherapy and subsequently underwent hematopoietic stem cell transplantation.

View Article and Find Full Text PDF

[The 5-year relative survival rate among cancer patients in Henan province of China, 2015-2019].

Zhonghua Zhong Liu Za Zhi

October 2024

Department of Disease Prevention and Control, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou 450008, China.

To analyze the 5-year relative survival rate of cancer in Henan province based on cancer registration data. Cancer survival data were extracted from the cancer registration database of Henan province with the diagnosis date between January 1, 2010 and December 31, 2019 were included. The closing date of follow-up was set as December 31, 2019.

View Article and Find Full Text PDF

Our goal was to assess the impact of prior cancer history on the prognosis of extranodal NK/T-cell lymphoma (ENKTCL). We searched the SEER database to retrospectively enroll patients with ENKTCL. The effects of cancer history on overall survival (OS) and disease-specific survival (DSS) were analyzed using the Cox model.

View Article and Find Full Text PDF

Inflammation plays a crucial role in cancer development. The neutrophil-to-lymphocyte ratio (NLR), a measure of inflammation, is obtained from a complete blood count. However, little is known about the association between NLR and cancer in the general adult population in the United States.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to predict the muscular invasion status of bladder urothelial carcinoma using advanced diffusion-weighted imaging techniques and compare the effectiveness of these techniques with the established VI-RADS system.
  • Patients with confirmed UCB underwent preoperative MRI, and several quantitative imaging parameters were analyzed to distinguish between non-muscle invasive and muscle-invasive cases.
  • The results showed that specific diffusion metrics (Axial diffusivity and Mean diffusivity) were strong predictors for muscle invasion, leading to a new MRI model that outperformed the VI-RADS system in diagnostic accuracy.
View Article and Find Full Text PDF
Article Synopsis
  • - The MONARCH plus study found that adding abemaciclib to endocrine therapy significantly improved progression-free survival (PFS) and objective response rate (ORR) in postmenopausal women with HR+/HER2- advanced breast cancer.
  • - In the study, cohort A (no prior systemic therapy) showed a median PFS of 28.27 months for abemaciclib users compared to 14.73 months for those on placebo, while cohort B (progression on prior therapy) showed 11.41 months vs. 5.59 months, respectively.
  • - Although abemaciclib was associated with some adverse events, they were manageable, and it demonstrated a trend toward overall survival (OS
View Article and Find Full Text PDF

Background: The phase 2 PERMEATE study has shown the antitumor activity and safety of pyrotinib plus capecitabine in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer and brain metastases. In this report, survival results were updated with extended follow-up.

Methods: Between January 29, 2019 and July 10, 2020, adult patients with HER2-positive metastatic breast cancer who had radiotherapy-naïve brain metastases (cohort A, n = 59) or progressive disease after radiotherapy (cohort B, n = 19) were enrolled and received pyrotinib (400 mg once daily) and capecitabine (1000 mg/m twice daily on days 1-14 of each 21-day cycle) until disease progression or unacceptable toxicity.

View Article and Find Full Text PDF

Background: To develop and validate an innovative predictive model that integrates multisequence magnetic resonance (MR) radiomics, deep learning features, and clinical indicators to accurately predict the recurrence of hepatocellular carcinoma (HCC) after thermal ablation.

Methods: This retrospective multicenter cohort study enrolled patients who were diagnosed with HCC and treated via thermal ablation. We extracted radiomic features from multisequence 3T MR images, analyzed these images using a 3D convolutional neural network (3D CNN), and incorporated clinical data into the model.

View Article and Find Full Text PDF
Article Synopsis
  • Adoptive cell therapy (ACT) is a new way to treat cancer by using special immune cells called T cells.
  • The success of ACT relies on how healthy and 'young' these T cells are, making them more powerful against cancer.
  • Researchers created a simple method to grow these strong T cells from blood samples, which keeps them in a better state for attacking cancer cells.
View Article and Find Full Text PDF

The Role of SIRT1 in Leukemia.

Curr Treat Options Oncol

October 2024

Department of Psychiatry, Henan Key Lab of Biological Psychiatry, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan of Xinxiang Medical University, Henan Collaborative Innovation Center of Prevention and treatment of mental disorder, The Second Affiliated Hospital of Xinxiang Medical University (Henan Mental Hospital), Xinxiang, 453002, China.

Leukemia is a type of hematological malignancy (HM) caused by uncontrolled proliferation, apoptosis, and differentiation of hematopoietic stem cells (HSCs). Leukemia cells proliferate greatly in the bone marrow (BM), infiltrate other tissues and organs, and affect the normal hematopoietic function. Although the emergence of new targeted agents and immune agents has improved the prognosis of patients, due to the complex pathogenic factors and heterogeneity of leukemia, there are still some patients with poor prognosis.

View Article and Find Full Text PDF
Article Synopsis
  • Microangiogenesis and lymphangiogenesis play a crucial role in the growth and spread of esophageal squamous cell carcinoma (ESCC), affecting tumor progression and patient prognosis.
  • A study analyzed 100 ESCC tissues and 100 adjacent normal tissues, measuring microvascular density (MVD) and lymphatic vessel density (LVD) using specific markers, revealing significantly higher levels in tumor tissues.
  • Both high MVD and LVD were linked to worse outcomes for patients, including increased lymph node metastasis and more advanced stages of cancer, suggesting that these markers can be valuable for assessing prognosis.
View Article and Find Full Text PDF

Background: The vast majority of pancreatic cancers have been shown to be insensitive to single-agent immunotherapy. Exploring the mechanisms of immune resistance and implementing combination therapeutic strategies are crucial for PDAC patients to derive benefits from immunotherapy. Deletion of BAP1 occurs in approximately 27% of PDAC patients and is significantly correlated with poor prognosis, but the mechanism how BAP1-deletion compromises survival of patients with PDAC remain a puzzle.

View Article and Find Full Text PDF

Reduced Platelet Activation in Triple-Negative Essential Thrombocythemia Compared with JAK2V617F-Mutated Essential Thrombocythemia.

Clin Cancer Res

December 2024

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

Article Synopsis
  • Triple-negative essential thrombocytopenia (TN-ET) lacks driver mutations but still meets diagnostic criteria, prompting a study to understand its clinical and molecular characteristics and link them to platelet activation and thrombotic risks.
  • A multicenter study compared 138 TN-ET patients to 759 ET patients with the JAK2V617F mutation, revealing that TN-ET patients tended to be younger and had fewer thrombotic events both before diagnosis and during follow-up.
  • Results indicated that TN-ET patients had lower platelet activation and reactive oxygen species (ROS) levels, correlating with a reduced risk of thrombosis compared to those with the JAK2V617F mutation.
View Article and Find Full Text PDF

Global burden of lung cancer in 2022 and projected burden in 2050.

Chin Med J (Engl)

November 2024

Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, Henan 450001, China.

Background: Lung cancer is the most common cancer and a leading cause of cancer-related deaths globally. The aim of this study was to evaluate the incidence and mortality of lung cancer worldwide in 2022 and to project the number of new cases and deaths due to lung cancer in China and the United States in 2050.

Methods: In this study, data from the GLOBCAN 2022 database were used to analyze lung cancer incidence and mortality.

View Article and Find Full Text PDF

Rosmarinic acid (RosA), a hydrophilic phenolic compound found in various plants, has several biological effects such as anti-inflammatory and anti-apoptosis activities. However, its potential impact on chronic obstructive pulmonary disease (COPD) and its underlying mechanism has not been investigated. In this study, we explored the potential therapeutic effects and mechanism of RosA on COPD airway inflammation and alveolar epithelial apoptosis and .

View Article and Find Full Text PDF

To determine the efficacy and safety of selinexor combined with venetoclax (VEN) and azactitidine (AZA) for patients with relapsed and/or refractory acute myeloid leukemia (R/R AML) . Twelve patients with R/R AML treated with selinexor plus VEN and AZA in the Affiliated Cancer Hospital of Zhengzhou University from May 2022 to May 2023 were included. Their clinical data were retrospectively analyzed.

View Article and Find Full Text PDF

[Disease burden and economic burden of breast cancer in females in China: a synthesis analysis].

Zhonghua Liu Xing Bing Xue Za Zhi

September 2024

Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.

To understand the current and integrated disease burden and economic burden caused by breast cancer in females in China. Based on six updated data sources, including the series of Chinese Cancer Registry Annual Report, China Death Cause Surveillance Datasets, China Health Statistical Yearbook, GLOBOCAN, Cancer Incidence in Five Continents, Global Burden of Disease Study (GBD), the information about incidence, mortality and disability adjusted life years (DALY) of breast cancer were extracted for the analysis on the current incidence and time trend of breast cancer and predicted disease burden of breast cancer in females in China. Software Joinpoint was used for time trend analysis.

View Article and Find Full Text PDF

Objectives: The possible interaction of prescription opioid use and physical activity with regard to depressive symptoms has not been well studied. This study aimed to investigate the joint effects of prescription opioid use and physical activity on depressive symptoms.

Study Design: Cross-sectional study.

View Article and Find Full Text PDF

Diagnosis and Treatment of Myxoid Liposarcoma.

Curr Treat Options Oncol

October 2024

Department of Bone and Soft Tissue Cancer, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Dongming Road 127, Zhengzhou, China.

Article Synopsis
  • - Myxoid liposarcoma (MLS) is a rare soft tissue sarcoma distinguished by its tendency to spread beyond the lungs and its unique MRI characteristics that help detect both primary and secondary tumors.
  • - It is defined by a specific genetic alteration (FUS-DDIT3 gene fusion), and diagnosis is crucial for determining treatment options. Surgery is the primary treatment, often combined with radiotherapy or chemotherapy to lower chances of local recurrence and improve survival rates.
  • - Ongoing research aims to create new therapies for advanced or unresectable MLS by studying its genetic and phenotypic traits, as well as the tumor's interaction with the immune system.
View Article and Find Full Text PDF

Optimizing CAR-T cell Culture: Differential effects of IL-2, IL-12, and IL-21 on CAR-T cells.

Cytokine

December 2024

Translational Medical Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Electronic address:

Article Synopsis
  • CAR-T therapy shows promise in treating blood cancers and is being explored for solid tumors and autoimmune diseases, but finding the best cytokine for maintaining CAR-T cells in lab conditions is still a challenge.
  • Using single-cell RNA sequencing, the study examined how different cytokines (IL-2, IL-12, IL-21) affect CAR-T cells, revealing that IL-2 and IL-12 lead to exhaustion and aging of the cells, while IL-21 helps prevent these issues.
  • The research highlights that incorporating IL-21 in CAR-T cell cultures may enhance their longevity by preserving their metabolic function, suggesting a potential combination strategy with other cytokines for better therapy outcomes. *
View Article and Find Full Text PDF

Research Progress on Ferroptosis in Multiple Myeloma.

Curr Treat Options Oncol

October 2024

Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, Henan, China.

Multiple myeloma (MM) is the second most common hematological malignant (HM) tumor, and a large proportion of patients still suffer from treatment failure and a poor prognosis despite the use of some newly approved drugs, a deeper understanding of the underlying mechanism is still needed. Ferroptosis is a new form of programmed cell death (PCD) that is different from other traditional forms of cell death such as apoptosis, necrosis and autophagy. With the continuous deepening of research on ferroptosis, ferroptosis has been found to be closely related to MM.

View Article and Find Full Text PDF

Background: Controversy still exists in the medical community regarding the performance of limited mediastinal lymphadenectomy (LML) in early-stage lung cancer. The objective of this study was to identify predictors of mediastinal lymph node (mLN) status and analyze its role in guiding surgical strategy.

Methods: A retrospective cohort study was conducted on 2,834 surgical patients with peripheral cT1N0M0 non-small cell lung cancer between 2016 and 2018.

View Article and Find Full Text PDF

Discovery of 2-Aryl-4-aminoquinazolin-Based LSD1 Inhibitors to Activate Immune Response in Gastric Cancer.

J Med Chem

September 2024

State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation, XNA Platform, Institute of Drug Discovery and Development, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.

LSD1 (histone lysine-specific demethylase 1) has been gradually disclosed to act as an immunomodulator to enhance antitumor immune response. Despite the identification of numerous potent LSD1 inhibitors, there remains a lack of LSD1 inhibitors approved for marketing. Novel LSD1 inhibitors with different mechanisms are therefore needed.

View Article and Find Full Text PDF

High-Dose Furmonertinib in Patients With EGFR-Mutated NSCLC and Leptomeningeal Metastases: A Prospective Real-World Study.

J Thorac Oncol

January 2025

Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, People's Republic of China; Institute of Cancer Research, Henan Academy of Innovations in Medical Science, Zhengzhou, People's Republic of China. Electronic address:

Article Synopsis
  • Leptomeningeal metastasis (LM) is a serious complication of non-small cell lung cancer (NSCLC), and this study investigates the effectiveness and safety of high-dose furmonertinib, a pan-EGFR tyrosine kinase inhibitor, for patients with this condition.
  • The study included 48 patients with EGFR-mutated NSCLC and LM, focusing on overall survival and clinical response rates, with participants receiving furmonertinib either alone or with other treatments.
  • Results showed a median overall survival of 8.43 months and a clinical response rate of 75%, while adverse events were consistent with previous findings, with some patients needing dosage adjustments due to side effects.
View Article and Find Full Text PDF